Pfizer’s oral antiviral treatment against COVID-19, Paxlovid, does not prevent coronavirus infection in people who live in the same household as someone who is infected with the coronavirus, the company announced. The discovery comes after a trial of 3,000 adults living in the same household as an individual who had recently tested positive for COVID-19 and who had obvious symptoms of the virus. The adults in the trial either took Paxlovid or a placebo for five days or 10 days. Those who took a five-day course of Paxlovid were found to be 32% less likely to become infected than the placebo group and 37% less likely after talking Paxlovid for 10 days.
Sign Up for Mideast Daily News
Wake up to the Trusted Mideast News source
By subscribing, you agree to The Media Line terms of use and privacy policy.